Sodium and potassium excretion changes and bone marrow recovery after chemotherapy.
Kiss
I
I
Tomasek
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002330:Carmustine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy; D011188:Potassium / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism*
D003561:Cytarabine; D005047:Etoposide; D003520:Cyclophosphamide; D012964:Sodium; D011188:Potassium; D002330:Carmustine